Neoadjuvant (induction) erlotinib response in stage IIIA non-small-cell lung cancer

被引：22
|
作者：
Kappers, Ingrid [1 ]
Klomp, Houke M. [1 ]
Burgers, Jacobus A. [2 ]
Van Zandwijk, Nico [2 ]
Haas, Rick L. M. [3 ]
van Pel, Renee [4 ]
机构：
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Surg Oncol, Amsterdam, Netherlands
[2] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands
[3] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands
[4] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 25期
关键词：
D O I：
10.1200/JCO.2008.16.3709
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：4205 / 4207
页数：3
相关论文
共 50 条
  • [41] Risk Associated with Bilobectomy after Neoadjuvant Concurrent Chemoradiotherapy for Stage IIIA-N2 Non-small-cell Lung Cancer
    Jong Ho Cho
    Jhingook Kim
    Kwhanmien Kim
    Young Mog Shim
    Hong Kwan Kim
    Yong Soo Choi
    World Journal of Surgery, 2012, 36 : 1199 - 1205
  • [42] Improved Survival Associated with Neoadjuvant Chemoradiation in Patients with Clinical Stage IIIA (N2) Non-Small-Cell Lung Cancer
    Poullis, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (11) : E100 - E100
  • [43] Risk Associated with Bilobectomy after Neoadjuvant Concurrent Chemoradiotherapy for Stage IIIA-N2 Non-small-cell Lung Cancer
    Cho, Jong Ho
    Kim, Jhingook
    Kim, Kwhanmien
    Shim, Young Mog
    Kim, Hong Kwan
    Choi, Yong Soo
    WORLD JOURNAL OF SURGERY, 2012, 36 (05) : 1199 - 1205
  • [44] Improved Survival Associated with Neoadjuvant Chemoradiation in Patients with Clinical Stage IIIA(N2) Non-Small-Cell Lung Cancer
    Koshy, Matthew
    Fedewa, Stacey A.
    Malik, Renu
    Ferguson, Mark K.
    Vigneswaran, Wickii T.
    Feldman, Lawrence
    Howard, Andrew
    Abdelhady, Khaled
    Weichselbaum, Ralph R.
    Virgo, Katherine S.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (07) : 915 - 922
  • [45] Neoadjuvant camrelizumab and chemotherapy in patients with resectable stage IIIA squamous non-small-cell lung cancer: Clinical experience of three cases
    Li, Xin
    Xia, Chunqiu
    Liu, Minghui
    Liu, Jinghao
    Dong, Ming
    Zhao, Honglin
    Xu, Song
    Wang, Dan
    Wei, Sen
    Song, Zuoqing
    Chen, Gang
    Liu, Hongyu
    Chen, Jun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] Effects of Neoadjuvant Radiotherapy on Survival in Patients with Stage IIIA-N2 Non-Small-Cell Lung Cancer Following Pneumonectomy
    Qu, Chenghao
    Li, Rongyang
    Han, Jingyi
    Yue, Weiming
    Tian, Hui
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [47] Second-line erlotinib for non-small-cell lung cancer
    Lorusso, Vito
    Cinieri, Saverio
    LANCET ONCOLOGY, 2012, 13 (04): : E141 - E142
  • [48] Clinical and economic review of erlotinib in non-small-cell lung cancer
    Yeung, Kai
    Carlson, Josh J.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (04) : 411 - 423
  • [49] Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer
    De Marinis, Filippo
    Gebbia, V.
    De Petris, L.
    ANNALS OF ONCOLOGY, 2005, 16 : 116 - 122
  • [50] Neoadjuvant Chemotherapy with Gemcitabine and Cisplatin in Stage IIIA/B Non-Small Cell Lung Cancer
    Maximiliano Van Kooten
    Moisés Rosenberg
    Mauro Orlando
    José Morero
    Manuel Vilanova
    Oscar Rojas
    Héctor Vicente
    Claudia Bagnes
    Carlos Silva
    Reinaldo D. Chacón
    Investigational New Drugs, 2002, 20 : 439 - 446
12345